Nexipraz 20mg, 40mg FC tablets
PDF Leaflet Revision Date: 14 August 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of gastric-oesophageal reflux disease and prevention of ulcers.
Dosage (summary)
40 mg once daily for erosive reflux; 20 mg once daily for maintenance.
Onset of Action / Duration
Onset: 1 hour, Duration: 24 hours
Special Populations
- Renal impairment
- Hepatic impairment
- Elderly
Pregnancy & Breastfeeding
Safety not established during pregnancy or breastfeeding.
Key Drug Interactions
- Clopidogrel
- Atazanavir
- Nelfinavir
- Methotrexate
- Tacrolimus
Contraindications
- Hypersensitivity to esomeprazole
- Co-administration with atazanavir and nelfinavir
Common side effects
- Headache
- Abdominal pain
- Diarrhoea
- Nausea
Counselling Points
- Take whole with liquid
- Monitor for symptoms of hypomagnesaemia
- Avoid long-term use if possible
Serious warnings
- Risk of Clostridium difficile diarrhoea
- Severe hypomagnesaemia
- Risk of fracture
Important Disclaimer
The Nexipraz 20mg, 40mg FC tablets professional information leaflet below is the property of Ranbaxy Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
